vs
PUMA BIOTECHNOLOGY, INC.(PBYI)与Urban Edge Properties(UE)财务数据对比。点击上方公司名可切换其他公司
Urban Edge Properties的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.8倍($132.6M vs $75.5M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs 12.2%),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs 11.6%)
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
Urban Edge Properties是一家上市房地产投资信托,主要在美国人口密集的城市及郊区市场持有、运营和开发优质零售及混合用途物业,投资组合涵盖生鲜超市锚定的购物中心、生活类商业网点等面向本地社区的资产。
PBYI vs UE — 直观对比
营收规模更大
UE
是对方的1.8倍
$75.5M
营收增速更快
PBYI
高出15.5%
12.2%
两年增速更快
PBYI
近两年复合增速
11.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $75.5M | $132.6M |
| 净利润 | — | $22.6M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | — |
| 净利率 | — | 17.1% |
| 营收同比 | 27.7% | 12.2% |
| 净利润同比 | — | -6.7% |
| 每股收益(稀释后) | $0.26 | $0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PBYI
UE
| Q1 26 | — | $132.6M | ||
| Q4 25 | $75.5M | $119.6M | ||
| Q3 25 | $54.5M | $120.1M | ||
| Q2 25 | $52.4M | $114.1M | ||
| Q1 25 | $46.0M | $118.2M | ||
| Q4 24 | $59.1M | $116.4M | ||
| Q3 24 | $80.5M | $112.4M | ||
| Q2 24 | $47.1M | $106.5M |
净利润
PBYI
UE
| Q1 26 | — | $22.6M | ||
| Q4 25 | — | $12.4M | ||
| Q3 25 | $8.8M | $14.9M | ||
| Q2 25 | $5.9M | $58.0M | ||
| Q1 25 | $3.0M | $8.2M | ||
| Q4 24 | — | $30.1M | ||
| Q3 24 | $20.3M | $9.1M | ||
| Q2 24 | $-4.5M | $30.8M |
毛利率
PBYI
UE
| Q1 26 | — | — | ||
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — |
营业利润率
PBYI
UE
| Q1 26 | — | — | ||
| Q4 25 | 22.7% | 11.3% | ||
| Q3 25 | 17.6% | 13.4% | ||
| Q2 25 | 12.7% | 53.9% | ||
| Q1 25 | 8.7% | 7.6% | ||
| Q4 24 | 22.6% | 27.6% | ||
| Q3 24 | 27.4% | 8.9% | ||
| Q2 24 | -4.6% | 30.6% |
净利率
PBYI
UE
| Q1 26 | — | 17.1% | ||
| Q4 25 | — | 10.4% | ||
| Q3 25 | 16.2% | 12.4% | ||
| Q2 25 | 11.2% | 50.8% | ||
| Q1 25 | 6.5% | 6.9% | ||
| Q4 24 | — | 25.9% | ||
| Q3 24 | 25.2% | 8.1% | ||
| Q2 24 | -9.6% | 28.9% |
每股收益(稀释后)
PBYI
UE
| Q1 26 | — | $0.18 | ||
| Q4 25 | $0.26 | $0.09 | ||
| Q3 25 | $0.17 | $0.12 | ||
| Q2 25 | $0.12 | $0.46 | ||
| Q1 25 | $0.06 | $0.07 | ||
| Q4 24 | $0.40 | $0.25 | ||
| Q3 24 | $0.41 | $0.07 | ||
| Q2 24 | $-0.09 | $0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $50.0M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $1.4B |
| 总资产 | $216.3M | $3.4B |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势,按日历期对齐
现金及短期投资
PBYI
UE
| Q1 26 | — | $50.0M | ||
| Q4 25 | $97.5M | $48.9M | ||
| Q3 25 | $94.4M | $77.8M | ||
| Q2 25 | $96.0M | $53.0M | ||
| Q1 25 | $93.2M | $48.0M | ||
| Q4 24 | $101.0M | $41.4M | ||
| Q3 24 | $96.7M | $67.9M | ||
| Q2 24 | $96.8M | $78.6M |
总债务
PBYI
UE
| Q1 26 | — | — | ||
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — |
股东权益
PBYI
UE
| Q1 26 | — | $1.4B | ||
| Q4 25 | $130.3M | $1.4B | ||
| Q3 25 | $115.3M | $1.4B | ||
| Q2 25 | $104.7M | $1.4B | ||
| Q1 25 | $97.1M | $1.4B | ||
| Q4 24 | $92.1M | $1.4B | ||
| Q3 24 | $71.1M | $1.3B | ||
| Q2 24 | $48.5M | $1.3B |
总资产
PBYI
UE
| Q1 26 | — | $3.4B | ||
| Q4 25 | $216.3M | $3.3B | ||
| Q3 25 | $202.9M | $3.3B | ||
| Q2 25 | $194.9M | $3.3B | ||
| Q1 25 | $196.2M | $3.3B | ||
| Q4 24 | $213.3M | $3.3B | ||
| Q3 24 | $220.7M | $3.2B | ||
| Q2 24 | $205.0M | $3.2B |
负债/权益比
PBYI
UE
| Q1 26 | — | — | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $14.4M | $39.1M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | 1.5% |
| 现金转化率经营现金流/净利润 | — | 1.73× |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势,按日历期对齐
经营现金流
PBYI
UE
| Q1 26 | — | $39.1M | ||
| Q4 25 | $14.4M | $182.7M | ||
| Q3 25 | $9.7M | $55.7M | ||
| Q2 25 | $14.1M | $43.5M | ||
| Q1 25 | $3.6M | $32.6M | ||
| Q4 24 | $15.6M | $153.2M | ||
| Q3 24 | $11.0M | $36.6M | ||
| Q2 24 | $1.0M | $41.2M |
自由现金流
PBYI
UE
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $81.8M | ||
| Q3 25 | $9.7M | $26.1M | ||
| Q2 25 | $14.1M | $19.6M | ||
| Q1 25 | $3.6M | $11.9M | ||
| Q4 24 | $15.6M | $42.5M | ||
| Q3 24 | $11.0M | $12.2M | ||
| Q2 24 | $1.0M | $19.9M |
自由现金流率
PBYI
UE
| Q1 26 | — | — | ||
| Q4 25 | 19.1% | 68.4% | ||
| Q3 25 | 17.7% | 21.7% | ||
| Q2 25 | 26.8% | 17.2% | ||
| Q1 25 | 7.7% | 10.0% | ||
| Q4 24 | 26.4% | 36.6% | ||
| Q3 24 | 13.7% | 10.8% | ||
| Q2 24 | 2.1% | 18.6% |
资本支出强度
PBYI
UE
| Q1 26 | — | 1.5% | ||
| Q4 25 | 0.0% | 84.4% | ||
| Q3 25 | 0.0% | 24.6% | ||
| Q2 25 | 0.0% | 20.9% | ||
| Q1 25 | 0.1% | 17.5% | ||
| Q4 24 | 0.0% | 95.1% | ||
| Q3 24 | 0.0% | 21.7% | ||
| Q2 24 | 0.0% | 20.1% |
现金转化率
PBYI
UE
| Q1 26 | — | 1.73× | ||
| Q4 25 | — | 14.71× | ||
| Q3 25 | 1.10× | 3.73× | ||
| Q2 25 | 2.41× | 0.75× | ||
| Q1 25 | 1.21× | 3.97× | ||
| Q4 24 | — | 5.09× | ||
| Q3 24 | 0.54× | 4.03× | ||
| Q2 24 | — | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
UE
| Rental revenue | $124.2M | 94% |
| Other | $8.4M | 6% |